End-of-day quote
Shanghai S.E.
06:00:00 2024-06-10 pm EDT
|
5-day change
|
1st Jan Change
|
21.46
CNY
|
+1.51%
|
|
-4.54%
|
-23.90%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
12,295
|
21,982
|
12,146
|
7,377
|
5,614
|
-
|
-
|
Enterprise Value (EV)
1 |
12,295
|
21,982
|
12,063
|
7,427
|
5,359
|
5,614
|
5,614
|
P/E ratio
|
58
x
|
92.3
x
|
78.7
x
|
-235
x
|
66
x
|
34.6
x
|
24.1
x
|
Yield
|
-
|
-
|
0.65%
|
0.64%
|
0.75%
|
1.63%
|
2.38%
|
Capitalization / Revenue
|
20.6
x
|
22.7
x
|
16.3
x
|
10.7
x
|
5.54
x
|
4.16
x
|
3.29
x
|
EV / Revenue
|
20.6
x
|
22.7
x
|
16.2
x
|
10.8
x
|
5.29
x
|
4.16
x
|
3.29
x
|
EV / EBITDA
|
56.7
x
|
67.6
x
|
50
x
|
175
x
|
27.1
x
|
16.9
x
|
12.7
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
8.64
x
|
13.8
x
|
7.19
x
|
4.67
x
|
3.38
x
|
3.13
x
|
2.87
x
|
Nbr of stocks (in thousands)
|
261,600
|
261,600
|
261,600
|
261,600
|
261,600
|
-
|
-
|
Reference price
2 |
47.00
|
84.03
|
46.43
|
28.20
|
21.46
|
21.46
|
21.46
|
Announcement Date
|
4/26/21
|
4/11/22
|
4/27/23
|
4/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
595.9
|
969.8
|
746.6
|
688.9
|
1,013
|
1,351
|
1,706
|
EBITDA
1 |
216.8
|
325.3
|
241
|
42.52
|
198
|
332
|
441
|
EBIT
1 |
192
|
283.7
|
178.3
|
-32.39
|
96.54
|
183.5
|
263
|
Operating Margin
|
32.23%
|
29.26%
|
23.88%
|
-4.7%
|
9.53%
|
13.59%
|
15.41%
|
Earnings before Tax (EBT)
1 |
191.8
|
287.9
|
176.7
|
-32.77
|
96.04
|
183.2
|
262.6
|
Net income
1 |
159
|
237.8
|
153.5
|
-32.31
|
84.66
|
162.4
|
232.9
|
Net margin
|
26.68%
|
24.53%
|
20.56%
|
-4.69%
|
8.35%
|
12.02%
|
13.65%
|
EPS
2 |
0.8100
|
0.9100
|
0.5900
|
-0.1200
|
0.3250
|
0.6200
|
0.8900
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
0.3000
|
0.1800
|
0.1600
|
0.3500
|
0.5100
|
Announcement Date
|
4/26/21
|
4/11/22
|
4/27/23
|
4/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 S1
|
2022 Q4
|
---|
Net sales
1 |
-
|
125.7
|
EBITDA
|
-
|
-
|
EBIT
1 |
-
|
22.23
|
Operating Margin
|
-
|
17.69%
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
|
101.4
|
-
|
Net margin
|
-
|
-
|
EPS
2 |
0.3900
|
0.0700
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
8/18/22
|
4/27/23
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
49.7
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
83.1
|
-
|
255
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
1.168
x
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
24.7%
|
15.9%
|
9.39%
|
-1.98%
|
5.12%
|
9.06%
|
11.9%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
7.93%
|
-1.66%
|
3.57%
|
7.02%
|
9.02%
|
Assets
1 |
-
|
-
|
1,935
|
1,942
|
2,372
|
2,313
|
2,582
|
Book Value Per Share
2 |
5.440
|
6.070
|
6.460
|
6.030
|
6.350
|
6.850
|
7.490
|
Cash Flow per Share
2 |
0.6400
|
0.3800
|
-0.2100
|
0.6900
|
-0.2700
|
1.190
|
-0.2500
|
Capex
1 |
-
|
-
|
229
|
227
|
255
|
92
|
118
|
Capex / Sales
|
-
|
-
|
30.67%
|
32.96%
|
25.16%
|
6.81%
|
6.92%
|
Announcement Date
|
4/26/21
|
4/11/22
|
4/27/23
|
4/26/24
|
-
|
-
|
-
|
Last Close Price
21.46
CNY Average target price
53
CNY Spread / Average Target +146.97% Consensus |
1st Jan change
|
Capi.
|
---|
| -23.90% | 775M | | -9.82% | 60.26B | | +62.86% | 45.41B | | +14.94% | 38.25B | | +1.31% | 31.37B | | +8.65% | 19.55B | | +11.65% | 16.64B | | +8.35% | 13.86B | | -6.09% | 12.84B | | -23.61% | 12.43B |
Other Commodity Chemicals
|